GMP in Latin America (ANVISA, COFEPRIS) – Pharma GMP

The Importance of ANVISA GMP Compliance for Pharmaceutical Manufacturers in Latin America

digi — Thu, 02 Jan 2025 02:06:00 +0000

The Importance of ANVISA GMP Compliance for Pharmaceutical Manufacturers in Latin America The Importance of ANVISA GMP Compliance for Pharmaceutical Manufacturers in Latin America Introduction to ANVISA GMP Compliance ANVISA (National Health Surveillance Agency) is the regulatory authority in Brazil responsible for ensuring the safety, efficacy, and quality of pharmaceutical products. For pharmaceutical manufacturers in...

How to Integrate ANVISA and COFEPRIS GMP Guidelines into Your Pharmaceutical QMS

digi — Wed, 01 Jan 2025 12:26:00 +0000

How to Integrate ANVISA and COFEPRIS GMP Guidelines into Your Pharmaceutical QMS How to Integrate ANVISA and COFEPRIS GMP Guidelines into Your Pharmaceutical QMS Introduction to ANVISA and COFEPRIS GMP Guidelines Good Manufacturing Practices (GMP) are a set of regulatory standards that ensure pharmaceutical products are produced consistently and controlled according to quality standards. In...

The Role of Regulatory Harmonization in ANVISA and COFEPRIS GMP Compliance

digi — Tue, 31 Dec 2024 22:46:00 +0000

The Role of Regulatory Harmonization in ANVISA and COFEPRIS GMP Compliance The Role of Regulatory Harmonization in ANVISA and COFEPRIS GMP Compliance Introduction to Regulatory Harmonization and Its Importance Regulatory harmonization refers to the process of aligning the regulatory requirements of different countries or regions to ensure consistency, mutual recognition, and efficiency in regulatory practices....

How ANVISA GMP Regulations Influence the Production of Vaccines

digi — Tue, 31 Dec 2024 09:06:00 +0000

How ANVISA GMP Regulations Influence the Production of Vaccines How ANVISA GMP Regulations Influence the Production of Vaccines Introduction to ANVISA and Vaccine Manufacturing Vaccines are one of the most important tools in global public health, preventing the spread of infectious diseases and saving millions of lives worldwide. The production of vaccines is a complex...

How COFEPRIS GMP Ensures the Quality of Biological Drugs

digi — Mon, 30 Dec 2024 19:26:00 +0000

How COFEPRIS GMP Ensures the Quality of Biological Drugs How COFEPRIS GMP Ensures the Quality of Biological Drugs Introduction to Biological Drugs and COFEPRIS GMP Biological drugs, also known as biologics, are a class of pharmaceuticals derived from living organisms or their components. These drugs, which include vaccines, monoclonal antibodies, gene therapies, and cell therapies,...

How to Achieve GMP Compliance for Pharmaceutical Packaging in Brazil

digi — Mon, 30 Dec 2024 05:46:00 +0000

How to Achieve GMP Compliance for Pharmaceutical Packaging in Brazil How to Achieve GMP Compliance for Pharmaceutical Packaging in Brazil Introduction to GMP Compliance for Pharmaceutical Packaging Pharmaceutical packaging plays a vital role in maintaining the safety, efficacy, and quality of drugs, ensuring that they reach consumers in the best possible condition. In Brazil, the...

How ANVISA GMP Guidelines Support Sustainable Manufacturing Practices in Brazil

digi — Sun, 29 Dec 2024 16:06:00 +0000

How ANVISA GMP Guidelines Support Sustainable Manufacturing Practices in Brazil How ANVISA GMP Guidelines Support Sustainable Manufacturing Practices in Brazil Introduction to ANVISA GMP and Sustainability in Manufacturing The National Health Surveillance Agency (ANVISA) is Brazil’s regulatory body responsible for overseeing the safety, efficacy, and quality of pharmaceutical products. While ANVISA’s primary goal is to...

How COFEPRIS GMP Supports the Manufacturing of Orphan Drugs

digi — Sun, 29 Dec 2024 02:26:00 +0000

How COFEPRIS GMP Supports the Manufacturing of Orphan Drugs How COFEPRIS GMP Supports the Manufacturing of Orphan Drugs Introduction to Orphan Drugs and COFEPRIS GMP Orphan drugs are pharmaceutical products developed to treat rare diseases, conditions, or disorders that affect a small population of patients. These conditions, often referred to as orphan diseases, may not...

How ANVISA GMP Guidelines Ensure Compliance for Pharmaceutical Exports

digi — Sat, 28 Dec 2024 12:46:00 +0000

How ANVISA GMP Guidelines Ensure Compliance for Pharmaceutical Exports How ANVISA GMP Guidelines Ensure Compliance for Pharmaceutical Exports Introduction to ANVISA GMP and Pharmaceutical Exports The National Health Surveillance Agency (ANVISA) is the regulatory body responsible for overseeing the safety, efficacy, and quality of pharmaceutical products in Brazil. ANVISA’s Good Manufacturing Practices (GMP) guidelines are...

COFEPRIS GMP and the Role of Biopharmaceutical Manufacturing in Mexico

digi — Fri, 27 Dec 2024 23:06:00 +0000

COFEPRIS GMP and the Role of Biopharmaceutical Manufacturing in Mexico COFEPRIS GMP and the Role of Biopharmaceutical Manufacturing in Mexico Introduction to COFEPRIS GMP and Biopharmaceutical Manufacturing The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) is the regulatory body in Mexico responsible for ensuring that pharmaceutical products meet safety, efficacy, and quality standards....